Market Overview
The Artificial Pancreas Device System (APDS) is an investigational device that mimics the function of a human pancreas. The FDA has provided recommendations for the design of clinical trials for the APDS. These recommendations cover the design, analysis, and data analysis of an APDS. The APDS requires sophisticated statistical data analyses to demonstrate safety and effectiveness. However, the research is still in its early stages.
Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/79
Market Dynamics
Rising prevalence of diabetes is expected to drive growth of the global artificial pancreas device system (APDS) market during the forecast period. According to the World Health Organization (WHO), the number of people with diabetes has increased from 108 million in 1980 to 422 million in 2014. According to the same source, in 2016, around 1.6 million deaths were directly caused due to diabetes. The artificial pancreas is a diabetes management system that tracks blood glucose levels with the help of a continuous glucose monitor (CGM) and automatically administers insulin when required using an insulin pump. Thus, such factors are expected to drive growth of the global artificial pancreas device system (APDS) market during the forecast period.
However, high costs associated with device and safety concerns is expected to restrain growth of the global artificial pancreas device system (APDS) market during the forecast period.
Impact of COVID-19
The artificial pancreas device system (APDS) market witnessed a significant decline during the COVID-19 pandemic. Following the outbreak in China, several countries closed down their borders and suspended international travel. Stringent regulations such as nationwide lockdown were implemented, in order to curb the spread of the virus. The growth of the market stagnated during the COVID-19 pandemic, typically due to massive disruption in the global supply chain industry. However, the launch of novel vaccines and declining cases are expected to aid in regaining the lost traction.
Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/79
Key Takeaways
-
The global artificial pancreas device system (APDS) market is expected to expand, exhibiting a CAGR of XY% over the forecast period. This is owing to the launch of novel products by key companies. For instance, in September 2020, Medtronic plc received the U.S. Food and Drug Administration (FDA) approval for a next-generation hybrid closed-loop insulin delivery system MiniMed 770G system for children aged 2 to 6 years with type 1 diabetes.
-
Among regions, Europe is expected to witness significant growth in the global artificial pancreas device system (APDS) market during the forecast period. This is owing to the presence of robust healthcare infrastructure and high patient awareness.
-
Asia Pacific is expected to register robust growth, owing to rapid urbanization and changing lifestyle of people.
-
Key companies involved in the global artificial pancreas device system (APDS) market are Medtronic plc, Johnson & Johnson, Tandem Diabetes Care, Inc., Pancreum, Inc., Bigfoot Biomedical, Inc., DexCom, Inc., Beta Bionics, Inc., and Insulet Corporation.
Reasons to Purchase this Report
• Current and future of global Artificial Pancreas Device System (APDS) Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/79
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Restraints
- Market Opportunities
- Impact Analysis
- Technology Assessment
- Reimbursement
- Regulatory Scenario
- Product Launch/Approval
- Merger and Acquisitions/Collaborations
- Product Pipeline Analysis
- Pricing Analysis
- PEST Analysis
- Market Dynamics
- Global Artificial Pancreas Device System (APDS) Market, By Technology, 2016 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Threshold Suspended Device Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Treat to Range/Control to Range (TTR/CTR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Treat to Target/ Control to Target (TTR/CTT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Artificial Pancreas Device System (APDS) Market, By Distribution Channel, 2016 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Retail Channel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Online Channel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Artificial Pancreas Device System (APDS) Market, By Region, 2016 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
- Market Size and Forecast, By Technology, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Technology, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Technology, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Technology, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Technology, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2027 (US$ Mn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Technology, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/artificial-pancreas-device-system-apds-market-to-surpass-us-025-billion-by-2024-36
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837